Sharp JG - Search Results

1

The multidrug resistance transporter ABCG2 (breast cancer resistance protein 1) effluxes Hoechst 33342 and is overexpressed in hematopoietic stem cells.

Kim M, Turnquist H, Jackson J, Sgagias M, Yan Y, Gong M, Dean M, Sharp JG, Cowan K. Kim M, et al. Among authors: sharp jg. Clin Cancer Res. 2002 Jan;8(1):22-8. Clin Cancer Res. 2002. PMID: 11801536

2

OMA-AML-1: a leukemic myeloid cell line with CD34+ progenitor and CD15+ spontaneously differentiating cell compartments.

Pirruccello SJ, Jackson JD, Lang MS, DeBoer J, Mann S, Crouse D, Vaughan WP, Dicke KA, Sharp JG. Pirruccello SJ, et al. Among authors: sharp jg. Blood. 1992 Aug 15;80(4):1026-32. Blood. 1992. PMID: 1379848 Free article.

3

Comparison of the growth and metastasis of four human intestinal tumor cell line xenografts.

Joshi SS, Jackson JD, Sharp JG. Joshi SS, et al. Among authors: sharp jg. Tumour Biol. 1989;10(3):117-25. doi: 10.1159/000217607. Tumour Biol. 1989. PMID: 2762735

4

Cell surface properties associated with malignancy of metastatic large cell lymphoma cells.

Joshi SS, Tilden PA, Jackson JD, Sharp JG, Brunson KW. Joshi SS, et al. Among authors: sharp jg. Cancer Res. 1987 Jul 1;47(13):3551-7. Cancer Res. 1987. PMID: 3581088

5

Differentiation inducing effects of butyrate and DMSO on human intestinal tumor cell lines in culture.

Joshi SS, Jackson JD, Sharp JG. Joshi SS, et al. Among authors: sharp jg. Cancer Detect Prev. 1985;8(1-2):237-45. Cancer Detect Prev. 1985. PMID: 4064044

6

The leukemic myeloid cell line OMA-AML-1: an in vitro model of hematopoietic cell differentiation.

Pirruccello SJ, Jackson JD, Sharp JG. Pirruccello SJ, et al. Among authors: sharp jg. Leuk Lymphoma. 1994 Mar;13(1-2):169-78. doi: 10.3109/10428199409051668. Leuk Lymphoma. 1994. PMID: 7517745

7

Erythropoietin for mobilization of circulating progenitor cells in patients with previously treated relapsed malignancies.

Kessinger A, Bishop MR, Jackson JD, O'Kane-Murphy B, Vose JM, Bierman PJ, Reed EC, Warkentin PI, Armitage JO, Sharp JG. Kessinger A, et al. Among authors: sharp jg. Exp Hematol. 1995 Jul;23(7):609-12. Exp Hematol. 1995. PMID: 7601251 Clinical Trial.

8

Outcome of high-dose therapy and autologous transplantation in non-Hodgkin's lymphoma based on the presence of tumor in the marrow or infused hematopoietic harvest.

Sharp JG, Kessinger A, Mann S, Crouse DA, Armitage JO, Bierman P, Weisenburger DD. Sharp JG, et al. J Clin Oncol. 1996 Jan;14(1):214-9. doi: 10.1200/JCO.1996.14.1.214. J Clin Oncol. 1996. PMID: 8558200

9

Effects of BCR-ABL antisense oligonucleotides (AS-ODN) on human chronic myeloid leukemic cells: AS-ODN as effective purging agents.

Wu AG, Joshi SS, Chan WC, Iversen PL, Jackson JD, Kessinger A, Pirruccello SJ, Sanger WG, Sharp JG, Verbik DJ, et al. Wu AG, et al. Among authors: sharp jg. Leuk Lymphoma. 1995 Dec;20(1-2):67-76. doi: 10.3109/10428199509054755. Leuk Lymphoma. 1995. PMID: 8750625

10

Increased hematopoietic progenitor cell maintenance in long-term bone marrow cultures containing minimal numbers of contaminating breast cancer cells.

Mann SL, Joshi SS, Crouse DA, Armitage JO, Kessinger A, Weisenburger DD, Vaughan WP, Sharp JG. Mann SL, et al. Among authors: sharp jg. Breast Cancer Res Treat. 1997 Jun;44(2):115-21. doi: 10.1023/a:1005732531318. Breast Cancer Res Treat. 1997. PMID: 9232270

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

199 results

Search Page

Filters